Disease Overview：Familial Adenomatous Polyposis（FAP）
Familial Adenomatous Polyposis (FAP) is an autosomal dominant hereditary disorder caused by germline mutations in the APC gene, leading to the development of hundreds to thousands of colorectal adenomatous polyps beginning in adolescence. Without intervention, near-universal progression to colorectal carcinoma occurs by age 40–50. Extracolonic manifestations include duodenal and gastric polyps, desmoid tumors, congenital hypertrophy of the retinal pigment epithelium (CHRPE), and increased risks of thyroid, brain, and hepatoblastoma cancers. Diagnosis relies on endoscopic identification of ≥100 colonic adenomas, genetic testing for APC pathogenic variants, and family history assessment. Prophylactic colectomy—typically total proctocolectomy with ileal pouch-anal anastomosis (IPAA) or subtotal colectomy with ileorectal anastomosis—is standard for confirmed FAP, supplemented by lifelong upper GI surveillance and multidisciplinary management.
China offers distinct advantages for FAP care: leading academic hospitals—such as Peking Union Medical College Hospital and Zhongshan Hospital—host specialized gastrointestinal genetics and polyposis clinics staffed by experts trained in international guidelines (e.g., ESGE, NCCN). Advanced endoscopic platforms (including high-definition chromoendoscopy and AI-assisted polyp detection), robotic-assisted surgery, and comprehensive molecular diagnostics support precision risk stratification and surveillance. Over 1,200 documented FAP cases managed annually across tier-1 centers demonstrate robust long-term outcomes, with 10-year pouch survival exceeding 92% and desmoid tumor control rates improved through integrated medical oncology protocols. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising evidence-based standards.
As a dedicated medical tourism agency, we facilitate seamless access for international patients: coordinating appointments with certified FAP specialists, verifying hospital accreditation and surgeon credentials, providing itemized, transparent pricing in advance, and delivering end-to-end support—from visa assistance and travel logistics to postoperative follow-up coordination and multilingual clinical interpretation.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Familial Adenomatous Polyposis (FAP)
Non-Surgical / Conservative Management
*Indicated for asymptomatic carriers, pre-colectomy surveillance, or contraindicated surgery.*
- •Annual Colonoscopy + Chromoendoscopy: $320–$480 (Grade 3A hospital; includes sedation, biopsy, pathology)
- •Upper GI Endoscopy (EGD): $260–$390 (every 1–2 years; includes duodenal biopsies)
- •Genetic Counseling & Testing (APC gene): $420–$580 (one-time; Sanger sequencing, variant interpretation)
- •Chemoprevention (Sulindac 150 mg BID): $25–$40/month (generic; requires 6-month LFT monitoring: $45/test)
- •Annual Abdominal Ultrasound (for desmoid tumor screening): $85–$120
Surgical / Procedural Interventions
*Eligibility: ≥10 adenomas, high-grade dysplasia, or symptomatic polyposis. Performed by GI Surgery/Colorectal Surgery.*
- •Prophylactic Total Colectomy with Ileorectal Anastomosis (IRA): $4,200–$6,100
- •Restorative Proctocolectomy with IPAA (J-pouch): $5,800–$8,300
- •Emergency Surgery (obstruction/perforation): $7,500–$10,200 (includes ICU stay, extended antibiotics)
Special/Complex Condition Management
- •Desmoid Tumor Resection (abdominal wall/mesentery): $6,400–$9,600 (requires intraoperative ultrasound + margin assessment)
- •Duodenal Polyposis (Spigelman Stage IV): Endoscopic mucosal resection (EMR) per session: $1,100–$1,700; pancreaticoduodenectomy (Whipple): $12,500–$16,800
- •Attenuated FAP (AFAP) Surveillance: Biennial colonoscopy ($320/session); no colectomy unless >20 polyps or cancer
Quick Selection Guide
- •<18 years, asymptomatic carrier: Genetic testing ($580) + annual colonoscopy ($480) — *optimal for surveillance, avoids surgery*
- •18–40 years, ≥20 colonic adenomas: IRA ($6,100) — *balances cancer prevention, bowel function, and cost*
- •>40 years, comorbidities (COPD/CHF): IRA over IPAA — *lower anastomotic leak risk, shorter recovery*
- •Desmoid tumor + unresectable location: Sulindac ($40/month) + monthly ultrasound ($120) — *first-line medical control before invasive intervention*
- •AFAP with low polyp burden: Biennial colonoscopy ($320) + EGD every 2 years ($390) — *avoids unnecessary surgery; cost-effective long-term*
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Familial Adenomatous Polyposis Medical Vacation Packages
Curated transparent all-inclusive packages combining Familial Adenomatous Polyposis treatment with China top medical destinations:
